Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    GLP-2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. / Burrin, D.G.; Stoll, B.; Guan, X.; Cui, L.; Chang, X.; Holst, Jens Juul.

    In: Endokrinologiya, No. 146, 2005, p. 22-32.

    Research output: Contribution to journalJournal articleResearch

  2. Published

    GLP-1 receptor argonists for the treatment of diabetes. / Holst, J.J.

    In: International Diabetes Monitor, No. 17, 2005, p. 11-18.

    Research output: Contribution to journalJournal articleResearch

  3. Published

    For debate: Are antidiabetic actions of DPP-IV inhibitors mediated by glucagon-like peptide- 1? / Holst, Jens Juul; Deacon, Carolyn F.

    In: Diabetologia, No. 48, 2005, p. 612-615.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. / Fehse, Frauke; Trautmann, Michael; Holst, Jens Juul; Halseth, Amy E; Nanayakkara, Nuwan; Nielsen, Loretta L; Fineman, Mark S; Kim, Dennis D; Nauck, Michael A.

    In: The Journal of clinical endocrinology and metabolism, Vol. 90, No. 11, 11.2005, p. 5991-7.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. / Fehse, F.; Trautmann, M.; Holst, J.J.; Halseth, A.E.; Nanyakkara, N.; Nielsen, L.; Fineman, M.S.D.; Kim, D.D.; Nauck, M.A.

    In: J. Clin. Endocrinol. Metab., No. 90, 2005, p. 5991-5997.

    Research output: Contribution to journalJournal articleResearch

  6. Published

    Evidence of an association between the Arg72-allele of the peptide YY (PYY) and increased risk of type 2 diabetes. / Torekov, S.S.; Larsen, L.H.; Glümer, C.; Borch-Johnsen, K.; Jørgensen, T.; Holst, Jens Juul; Madsen, O.D.; Hansen, T.; Pedersen, O.

    In: Diabetes, No. 54, 2005, p. 2261-2265.

    Research output: Contribution to journalJournal articleResearch

  7. Published

    Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes. / Torekov, Signe S; Larsen, Lesli H; Glümer, Charlotte; Borch-Johnsen, Knut; Jørgensen, Torben; Holst, Jens J; Madsen, Ole D; Hansen, Torben; Pedersen, Oluf.

    In: Diabetes, Vol. 54, No. 7, 2005, p. 2261-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Evidence for an endocrine pancreatico-gastric axis: The role of pancreatic polypeptide in gastric emptying and short term metabolic control. / Schmidt, P.T.; Näslund, E.; Grybäck, P.; Jacobsson, H.; Holst, J.J.; Hilsted, L.; Hellström, P.M.

    In: J. Clin. Endocrinol. Metab., No. 90, 2005, p. 5241-5246.

    Research output: Contribution to journalJournal articleResearch

  9. Published

    Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. / Meier, Juris J; Kemmeries, Guido; Holst, Jens Juul; Nauck, Michael A.

    In: Diabetes, Vol. 54, No. 7, 07.2005, p. 2212-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Erythromycin antagonises the deceleration of gastric emptying by glucagon-like peptide-1 (GLP)-1 and unmasks its insulinotropic effect in healthy subjects. / Meier, J.J.; Kemmeries, G.; Holst, Jens Juul; Nauck, M.A.

    In: Diabetes, No. 54, 2005, p. 2212-2218.

    Research output: Contribution to journalJournal articleResearch

ID: 4207